Establishing Causal Relationship: Long COVID Biomarkers

                               

Identifiable biomarkers may provide objective evidence in proving a Long COVID claim. A recent report highlights developments in identifying the risk of Long COVID through immune profiling. 

SARS-CoV-2 infection can result in the development of a constellation of persistent sequelae following acute disease called post-acute sequelae of COVID-19 (PASC) or Long COVID1–3. 

 

 

Individuals diagnosed with Long COVID frequently report unremitting fatigue, post-exertional malaise, and a variety of cognitive and autonomic dysfunctions1–3; however, the basic biological mechanisms responsible for these debilitating symptoms are unclear. 

By Jon L. Gelman

Courtesy of Workers' Compensation

Request a Demo

To request a free demo of one of our products, please fill in this form. Our sales team will get back to you shortly.